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Abstract
Background: The cellular and molecular mechanisms of inflammatory bowel disease are not fully understood;
however, data indicate that uncontrolled chronic inflammation induced by bacterial gene products, including
lipoteichoic acid (LTA), may trigger colonic inflammation resulting in disease pathogenesis. LTA is a constituent
glycolipid of Gram-positive bacteria that shares many inflammatory properties with lipopolysaccharide and plays a
critical role in the pathogenesis of severe inflammatory responses via Toll-like receptor 2. Accordingly, we elucidate
the role of LTA in immune stimulation and induced colitis in vivo.
Methods: To better understand the molecular mechanisms utilized by the intestinal microbiota and their gene
products to induce or subvert inflammation, specifically the effect(s) of altered surface layer protein expression on
the LTA-mediated pro-inflammatory response, the Lactobacillus acidophilus surface layer protein (Slp) genes
encoding SlpB and SlpX were deleted resulting in a SlpB
- and SlpX
- mutant that continued to express SlpA
(assigned as NCK2031).
Results: Our data show profound activation of dendritic cells by NCK2031, wild-type L. acidophilus (NCK56), and
purified Staphylococcus aureus-LTA. In contrary to the LTA-deficient strain NCK2025, the LTA-expressing strains
NCK2031 and NCK56, as well as S. aureus-LTA, induce pro-inflammatory innate and T cell immune responses in
vivo. Additionally, neither NCK2031 nor S. aureus-LTA supplemented in drinking water protected mice from
DSS-colitis, but instead, induced significant intestinal inflammation resulting in severe colitis and tissue destruction.
Conclusions: These findings suggest that directed alteration of two of the L. acidophilus NCFM-Slps did not
ameliorate LTA-induced pro-inflammatory signals and subsequent colitis.
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Background
The intestinal immune system must co-exist with resi-
dent commensal microorganisms while maintaining the
ability to defend against potential microbial challenge.
This immune tolerance is a highly regulated process
comprised of a myriad of biological checkpoints neces-
sary to maintain homeostasis between the host and the
gut microbiota [1]. In instances of inflammatory bowel
disease (IBD), this tolerance between immune cells and
intestinal bacteria is disrupted; however, causes of this
tolerance breakdown have not yet been determined
[2,3]. Although the etiology of IBD is still unknown,
exaggerated inflammation induced by activated innate
immune cells via their interaction with the microbiota
and their gene products, as well as infiltrating CD4
+
IFNg
+ T cells, likely play key roles in uncontrolled
inflammation and tissue destruction [4-6]. Foxp3
+ regu-
latory T cells (Tregs) also critically control intestinal
inflammation [7] and significantly prevent colitis [8],
suggesting a pivotal role for Tregs in intestinal immune
homeostasis [9].
A fundamental challenge in preventing an imbalanced
immune response is the understanding of how the host
immune system distinguishes a pathogen from normal
intestinal flora. One of the commensal microorganisms
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face layer proteins (Slps), including A, B, X, and abun-
dant lipoteichoic acid (LTA). LTA is a zwitterionic
glycolipid found in the cell wall of several Gram-positive
bacterial strains, including L. acidophilus, which facili-
tates the adhesion, colonization, and invasion of cells by
t h eb a c t e r i a[ 1 0 , 1 1 ] .T h eb e s ts t u d i e df o r mo fL T Ai s
composed of a polyglycerophosphate chain that is teth-
ered to the membrane via a glycolipid anchor [12]. Stu-
dies indicate that LTA shares many of the inflammatory
properties of lipopolysaccharide (LPS) via interactions
with Toll-like receptors (TLRs) [13-16] which evoke
diverse responses in innate cells through distinct signal-
ing cascades [17].
Previously, we have demonstrated that deletion of the
gene responsible for LTA biosynthesis in L. acidophilus
NCFM diminishes this bacterium’s capacity to stimulate
the immune system; thereby suppressing pathogenic
CD4
+T cells in induced colitis [18,19]. To further inves-
tigate the role of LTA in inflammation, we engineered
the NCK2031 strain in order to evaluate the effects, if
any, of altered surface layer protein (Slp) expression on
LTA-induced pro-inflammatory signals and colitis.
Methods
Materials Six to 8-week-old C57BL/6 were purchased
from Jackson Laboratories (Bar Harbor, ME). Mice were
maintained in microisolator cages under specific patho-
gen-free, Helicobacter-free conditions. Experiments were
performed in an accredited establishment according to
NIH guidelines in the Guide for Care and Use of
Laboratory Animals (NIH-72-23), and animal protocols
were approved by the local ethics committee. Dextran
Sulfate Sodium (DSS) was obtained from MP Biochem-
icals (Solon, OH). Monoclonal antibodies for CD4,
CD25, CD3, CD11c, CD11b, CD40, CD44, CD80, CD83,
CD86, CD103, IL-10, IL-12, IFNg,T N F a,H L A - A B C
(R&D systems, Minneapolis, MN) and (BD, Franklin
Lakes, NJ), CD1a (Dako, Carpentaria, CA), mouse and
human GM-CSF and IL-4 were purchased from Invitro-
gen (Carlsbad, CA).
Generation of NCK2031 To generate an L. acidophilus
NCFM isogenic mutant defective in all three slp genes
(slpA, slpB,a n dslpX), the slpB (LBA0175) and slpX
(LBA0512) genes were sequentially deleted in an
NCFMΔupp background host (NCK1909) using the
upp-based counterselective gene replacement system
[20]. Subsequently, attempts to insertionally inactivate
the slpA gene (LBA0169) were made within the ΔslpBX
double mutant (NCK2030) using a pORI-based gene
knockout system [21]. The resulting ΔslpBX strain was
deficient in SlpB and SlpX, but due to genetic instability
of the insertion vector, NCK2031 continued to express
SlpA (data not shown). Subsequently, wild-type L.
acidophilus (NCK56), NCK2031, or LTA-deficient
NCK2025 were propagated in de Man, Rogosa, and
Sharpe broth (MRS, Difco) at 37°C for 15 hrs. The con-
centration of each L. acidophilus strain was adjusted to
1×1 0
9 CFU/ml based on OD600 readings that had pre-
viously been correlated with CFU numbers [22]. Each
mouse was orally treated with 5 × 10
8 CFU bacterial
strain; therefore 500 μlo f1×1 0
9 CFU/ml suspension
was centrifuged, pelleted and then resuspended in 100
μl of PBS. Each mouse was then treated with 100 μl
PBS (control group) or 5 × 10
8 CFU (of either L. acido-
philus strain) orally in100 μl sterile PBS. Fecal pellets
were collected from before, during, and for up to 8 days
after L. acidophilus oral treatments. Each fecal pellet
was resuspended in PBS (1:10 dilution, w/v). The sus-
pension was then serially diluted and plated onto MRS
agar containing Em (2 μg/mL). The homogenized mate-
rial was serially diluted and plated onto MRS agar con-
taining Em (2 μg/mL). The daily average CFU of the L.
acidophilus strains in mouse feces were determined. For
in vitro stimulation, bone marrow or human monocyte
derived DCs were stimulated at a 1:1, 1:10, 1:100 ratio
with live NCK2031, NCK56, NCK2025, or S. aureus-
LTA. Subsequently the ratio of 1:1 was chosen, as this
did not overwhelmingly activate DCs and therefore did
not result in cell anergy or apoptosis. For the oral
gavage of mice, each mouse received 5 × 10
8 CFU of
NCK2031, NCK56, or NCK2025 in 100 μL of PBS.
Cell culture Immature human [22,23] or murine DCs
[24] were treated with live L. acidophilus strains cells at
1:1 or with S. aureus-LTA (50 μg/mL) for 24 hrs. L.
acidophilus-o rS. aureus-LTA treated and untreated
DCs (5 × 10
5) were then stained and analyzed by BD
FACSCaliber or a multicolor FACSCanto. Cell superna-
tants were also collected and analyzed using cytometric
bead array kits (BD Biosciences). At least 1 × 10
4 gated
events per condition were acquired. Analysis software
(BD CellQuest) allowed for calculation of cytokine
values in supernatants at pg/mL.
Immunofluorescence The colons of mice (n = 5/
group) treated with live NCK2031, NCK56, NCK2025, S.
aureus-LTA, or PBS alone were fillet-opened, rolled,
and snap frozen at -80°C in Tissue-Tek O.C.T. (Sakura
Finetek USA, Inc., Torrance, CA). Sections (5 μm) were
cut, fixed in ice-cold methanol (-20°C) for 15 min and
blocked with 1% BSA. Sections were then incubated
o v e r n i g h ta t4 ° Cw i t hp u r i fied hamster anti-mouse
CD11c (BD Biosciences) and rat anti-mouse IL-10 (Bio-
Legend), and antibodies for IL-12, IFNg,T N F a,C D 8 ,
and Foxp3, followed by washing twice with PBS and
incubation with anti-hamster AlexaFluor 594 and anti-
rat AlexaFluor 488 (Invitrogen) for 1 hr. Sections were
then washed twice with PBS and incubated for 10 min-
utes with 4,6-diamidino-2-phenylindole dihydrochloride
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mounted with anti-fade mounting medium, as described
previously [25]. Images were acquired using TissueG-
nostics Tissue/Cell High Throughput Imaging and Ana-
lysis System and analyzed using ImageJ software.
Flow cytometry Groups of mice (5 mice/group) were
inoculated orally with NCK2031, NCK56, NCK2025, or
S. aureus-LTA (5 × 10
8 CFU/100 μLo fs t e r i l eP B S /
mouse) or PBS alone. Mice were then sacrificed after 1,
3, or 7 days; single cells were isolated from the colons
[18], MLNs, and spleens and stained with CD11c,
CD11b, CD103, MHC II, CD40, CD80, CD86, F4/80,
CD4, CD3, CD80, or CD44 [26]. Stained cells were then
fixed, permeabilized, and stained with IL-12, TNFa,
IFNg or isotype antibodies. At least 1 × 10
5 gated events
per condition were acquired. Data were acquired with
BD FACSCanto II and analyzed using Tree Star FlowJo
software.
DSS-Induced Murine Colitis Groups of C57BL/6 mice
(n = 5/group) were inoculated orally with NCK2031,
NCK56, NCK2025, or (5 × 10
8 CFU/100 μLP B S /
mouse) for four consecutive days. In addition, a group
of mice was treated with purified S. aureus-LTA (12.5
μg/μL) [27] for 5 days. All of these mice received one 5-
day cycle of 3% DSS in drinking water, followed by 3
days of regular drinking water, with or without S. aur-
eus-LTA, and then sacrificed on day 13. Acute colitis
was observed after the first cycle of DSS in the non-
inoculated group. Disease progression, including weight
loss, diarrhea and fecal hemoccult blood positivity
(FOB), was monitored throughout the study. Thereafter,
mice were sacrificed and excised colon cross-sectional
Swiss rolls were fixed in 10% formaldehyde and
embedded in paraffin. Tissue sections (4 μm) were
stained with hematoyxylin and eosin (H&E), and blindly
scored, as described previously [28,29]. The grading,
based on a scale from 0 to 28, takes into account the
degree of inflammatory infiltrate, the presence of ero-
sion, ulceration, or necrosis, and the depth and surface
extension of the lesion.
Results
Immune stimulation by NCK2031
To further characterize the role of LTA expression in
inflammation, we attempted to generate surface layer
protein (Slp)-deficient strains using the upp-counterse-
lective gene replacement system [20]. The resulting
strain, NCK2031, showed no detectable expression of
SlpB or SlpX while retaining LTA expression.
Attempted insertional mutation in the slpA gene was
unstable and spontaneous SlpA
+ revertants occurred in
the population. Therefore, the phenotype of this mutant
was defined as SlpA
+B
-X
-LTA
+.S D S - P A G Ea n a l y s e s
confirmed the expression of SlpA only (at 46 kDa), and
the absence of SlpB and SlpX within the NCK2031
culture (data not shown). To evaluate any in vivo physio-
logical effects of NCK2031 and its colonization in the gut
of bacteria treated mice, the persistence of erythromycin-
resistant (Em
r)N C K 5 6a n dE m
r NCK2031 strains in the
colon were determined in C57BL/6 mice orally treated
once with 5 × 10
8 CFU/mouse. Fecal pellets were col-
lected the day before treatment and every day for up to 8
days after bacterial ingestion. Data reveal that mice
cleared both NCK2031 and NCK56 (wild type) after 3
days, with significantly less NCK2031 excreted on days 2
and 3 (Figure 1a). Therefore, while the trends for clear-
ance of the orally fed bacteria were similar, deletion of
the SlpB and SlpX proteins appeared to accentuate clear-
ance of the bacterium from the GI tract by one day, in
vivo. Determining the time of bacterial clearance from
the gut was essential to delineate the sampling time
points used in the immunological studies.
To elucidate the physiological role of NCK2031 in
dendritic cell (DC) activation, we co-cultured human
monocyte derived DCs with NCK2031, NCK56,
NCK2025, or purified S. aureus-LTA. Data revealed that
the parent strain NCK56, the SlpA
+B
-X
-LTA
+ strain
NCK2031, and S. aureus-LTA profoundly stimulated
human DCs, while the SlpA
+B
+X
+LTA
- strain NCK2025
only marginally modified DC function (Figure 1b, c).
Additionally, murine bone marrow derived DCs co-cul-
tured with NCK2031 exhibited an up-regulation of
MHC II, CD80, CD86, CD40, and increased production
of intracellular interleukin (IL)-12 and TNFa when
compared to DCs cultured with NCK56, NCK2025 or S.
aureus-LTA (Figure 1d). These data indicate that LTA
is not playing a regulatory role as seen in other studies
[27,30], but rather, functions as a highly pro-inflamma-
tory molecule when expressed on L. acidophilus [19].
Activation of DCs, macrophages, and T cells by NCK2031
To overcome the undesired effects of cell death induced
by enzymatic reagents (i.e. collagenase) necessary for
cell isolation we employed TissueGnostics fluorescent
microscopy [18] and confocal microscopy (Figure 2a, 3a)
to analyze the cell populations and their cytokine
expression in the colons of bacteria treated mice. As
demonstrated previously, a significantly higher percen-
tage of CD11c
+IL-10
+ DCs per total DAPI
+ cells were
observed in the colons of mice treated with NCK2025
when compared to mice treated with NCK2031, NCK56,
or S. aureus-LTA on days 1 and 3, but not by day 7
(data not shown). In contrast, IL-12 and TNFa produc-
tion by colonic DCs was significantly higher in mice
treated with NCK2031, NCK56, or S. aureus-LTA when
compared to mice that were treated with NCK2025 or
PBS (Figure 2b). To expand upon these findings, we stu-
died the ability of the LTA-expressing strains to induce
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+ and CD8
+
T cells in vivo. While no significant differences were
seen in the expression of MHC II, CD40, CD80, or
CD86 on CD11c
+CD11b
+DCs or CD11b
+F4/80
+ macro-
phages (data not shown), cytoplasmic IL-12 and TNFa
were significantly increased in CD11c
+ MHC II
+ DCs
derived from the colons (Figure 2c), and mesenteric
lymph nodes (MLNs) (Figure 3a), but not the spleens of
mice that were treated with NCK2031, NCK56, or S.
aureus -LTA versus PBS or NCK2025 (Figure 3b).
Recent studies have indicated that there is a significant
recruitment of colonic F4/80
+ macrophages in IBD com-
pared to that seen in normal mucosa [31]. Thus, we
investigated the impact of the genetically modified
strains versus the wild type NCK56 and S. aureus-LTA
on the recruitment and activation of colonic F4/80
+
macrophages in vivo. Based on data generated by Tis-
sueGnostics, it was apparent that NCK2031, NCK56,
and S. aureus-LTA significantly induced colonic F4/80
+
macrophages to produce IL-12 and TNFa;t h e
expression of these cytokines was low in NCK2025-
treated mice after 24 hrs (Figure 4a, b), but had leveled
off by days 3 and 7 (data not shown). In contrast, IL-10
was highly expressed in NCK2031, NCK56, NCK2025,
and S. aureus-LTA treated mice compared to untreated
mice (Figure 4c). This observation may reflect the nat-
ure of the bacteria and their gene products, which can
differentially stimulate these colonic cells to become
either pro-inflammatory or regulatory. These data sug-
gest that activation of intestinal cells and induction of
inflammation may be triggered by the presence of LTA,
as previously shown in lungs with airway inflammation
[32,33].
In addition, colonic CD4
+T cells from mice treated
with NCK2031, NCK56, or S. aureus-LTA expressed
higher levels of IFNg compared to mice treated with
NCK2025 or PBS (Figure 5a). Treatment of mice with
NCK2031, NCK56, and S. aureus-LTA also induced
significantly increased expression of IFNg and TNFa (Fig-
u r e5 b ) ,b u tn o tI L - 1 7( d a t an o ts h o w n ) ,i nt h eC D 4
+ T
Figure 1 Persistence of NCK56 and NCK2031 in the gut. (a) Groups of mice (n = 3) were orally treated with (Em
r)-resistant NCK56 or
NCK2031 (5 × 10
8 CFU/20 μL/mouse). Fecal pellets were collected from before, during, and up to 8 days after bacterial oral treatments, and
dissolved in 10% MRS. The homogenized materials were serially diluted and plated onto MRS agar containing Em (2 μg/mL). The daily average
CFU of the L. acidophilus strains in the mouse feces were determined. These data are representative of at least three independent experiments.
Activation of DCs by NCK2031.(b, c, d) Human or bone marrow derived DCs were activated with live NCK2031, NCK56, NCK2025, or S. aureus
LTA (50 μg/ml) for 24 hrs at 37°C. Cells were harvested and phenotypically characterized by a FACSCaliber or a multicolor FACSCanto II. Cell
supernatants were analyzed for cytokines by CBA using a FACSCaliber. Experiments were repeated at least five times with similar results. Data
were statistically analyzed by one-way ANOVA, *P< 0.05 indicates statistically significant differences between the study groups.
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Page 4 of 12Figure 2 Stimulation of cells by L. acidophilus strains. Excised colons from untreated (PBS) mice (n = 5/group) and mice (n = 5/group)
treated with NCK2031, NCK56, NCK2025, or S. aureus LTA were stained with CD11c, TNFa, IL-12, or CD4, IFNg, and visualized by UV LSM. White
size bar represents 20 μm. White arrows point to the co-localized cells in yellow dots. (a) Representation of CD11c
+/TNFa
+, CD11c
+/IL-12
+ cells
(yellow, merged red/green/blue). White size bar represents 50 μm. White arrows point to the co-localized cells in yellow dots. (b) Quantitative
analyses of IL-12 and TNFa
+ by TissueGnostics Tissue/Cell High-Throughput Imaging and Analysis System. (c) Induction of colonic DC-activation
by L. acidophilus expressing LTA. Single cells were derived from colons of the mice (n = 5/group) treated with NCK20331, NCK56, NCK2025, or
PBS. Cells were stained with anti-CD11c, CD11b, CD103, MHC II, CD19, F4/80, IL-12, or TNFa antibodies. Live CD11c
+ cells that were F4/80
-CD19
-
were analyzed for their cytokine expression and expression of surface molecules (i.e., MHC II) by FACSCanto II. Experiments were repeated at
least three times with similar outcomes.
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the spleen (data not shown). The CD4
+ cells seemed to be
less affected in the NCK2025-treated mice (Figure 5b).
It has recently been demonstrated that CD8
+T cells
efficiently prevent the generation of colitis [34,35] and
play a critical role in controlling potentially pathogenic
T cells [36] in IBD patients [37,38]. Such CD8
+T cells
with regulatory activity reside in the lamina propria
(LP) of healthy individuals but not in the LP of patients
with IBD [37,38]. Interestingly, the percentages of CD8
+T cells in the colons of mice treated with NCK2031,
NCK56, or S. aureus-LTA were significantly reduced
(data not shown) when compared to NCK2025 treated
mice. The majority of CD8
+T cells in the colonic tissues
from all groups of mice were IFNg negative (data not
shown), suggesting that colonic CD8
+T cells are prob-
ably not involved in immune stimulation; rather, they
exert immune regulation in the colon [36]. To demon-
strate whether resident or recruited colonic CD8
+ T cells
are Foxp3
+, these cells were visualized by TissueGnostics
fluorescent microscopy. Surprisingly, there were no
significant differences in Foxp3
+ expression between the
groups of the mice that were treated with the various
L. acidophilus strains or S. aureus-LTA (data not shown).
Further studies are required to study this cell type in coli-
tis disease models. The activity of CD8
+ T cells within
the MLN and spleen was also analyzed. NCK2031,
NCK56, and S. aureus-LTA significantly stimulated MLN
CD8
+CD44
high T cells to produce IFNg on day 3 and
TNFa on day 7 (Figure 5c); no significant differences in
the production of these cytokines were seen in the
splenic CD8
+ T cells (data not shown). Collectively, these
data indicate that the LTA-expressing strains, NCK2031
and NCK56, activate DCs and macrophages in a pro-
Figure 3 Activation of mesenteric DCs by L. acidophilus strains. (a-b) Single cells were derived from mesenteric lymph nodes (MLN) or
spleens of the mice (n = 5/group) treated with NCK2031, NCK56, NCK2025, or PBS. Cells were stained with anti-CD11c, CD11b, CD103, MHC II,
CD19, F4/80, IL-12, or TNFa antibodies. Live CD11c
+ cells that were F4/80
-CD19
- were analyzed for their cytokine expression and expression of
surface molecules (i.e., MHC II) by FACSCanto II. Experiments were repeated at least three times with similar outcomes.
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+ macrophages. (a-c) Quantitative analysis of (a) F4/80
+ TNFa
+, (b) F4/80
+IL-12
+ (c) F4/80
+IL-10
+ in
untreated (PBS) mice and in mice treated with NCK2031, NCK56, NCK2025, and S. aureus-LTA. Data were statistically analyzed by one-way
ANOVA, *P< 0.05 indicates significance of the data between the study groups.
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+(a, b) and CD8
+T cells (c) by L. acidophilus expressing LTA. After treatment of mice with PBS, NCK2031, NCK56,
or NCK2025, lymphocytes were isolated from MLNs and spleens (not shown) after 1, 3 or 7 days and stained with live/dead, CD3, CD4, CD8, and
CD44. Cells were fixed, permeabilized and intracellularly stained with TNFa, IFNg and analyzed by FACSCanto II. Dead cells and doubles were
excluded from analyses. Experiments were repeated at least three times with similar outcomes. Data were statistically analyzed by one-way
ANOVA, *P< 0.05 indicates statistically significant differences between the study groups.
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Page 8 of 12inflammatory manner, which in turn, may directly elicit
CD4
+ and CD8
+ T cell activation.
Exacerbation of DSS-induced murine colitis by NCK2031
and S. Aureus-LTA
To more thoroughly investigate the pro-inflammatory
mechanisms induced by LTA, we utilized the DSS-
mouse model for colitis [18]. Data show that DSS
generated murine colitis in PBS-treated mice (Figure 6a-
d). Mice began to lose weight after day 8 and developed
severe diarrhea at days 10-13 (Figure 6b, c). To specifi-
cally address the role of LTA expression by NCK2031,
mice were treated with NCK2031, NCK56, NCK2025 or
S. aureus-LTA dissolved in drinking water. NCK2031,
NCK56, or soluble S. aureus-LTA did not prevent the
onset of colitis and the mice developed colitis similarly
Figure 6 DSS-induced murine colitis. C57BL/6 mice (n = 5/group) were orally inoculated with NCK2031, NCK56, NCK2025 (5 × 10
8 CFU/100
μL/mouse) or PBS for 4 consecutive days. S. aureus-LTA (12.5 μg/μL) was dissolved in the drinking water and provided to the mice until day 13.
These groups of mice were exposed to 3% DSS dissolved in the drinking water for 5 days followed by 7 days of plain water and assessed over
time for colitis, including (a) hematoyxylin & eosin (H&E) staining, (b) weight loss, (c) diarrhea, and (d) disease activity index (DAI). Data are
representative of at least three independent experiments.
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with NCK2025 significantly prevented weight loss and
reduced diarrhea (Figure 6), as previously documented
[18]. Overall, the “Disease Activity Index” (DAI) was
significantly increased for untreated animals and mice
treated with NCK2031, NCK56, and S. aureus-LTA (Fig-
ure 6d). The colons from these mice exhibited ulcerated
epithelium with significant inflammation confined to the
mucosa, while colonic tissue obtained from mice treated
with NCK2025 did not exhibit evidence of significant
inflammation (Figure 6a).
Discussion
Excessive stimulation of intestinal innate cells, including
DCs, with commensal bacteria and/or their gene pro-
ducts results in immune dysfunction that can generate
uncontrolled inflammation leading to tissue destruction
and colitis [39]. Precise cellular and molecular mechan-
isms of these induced inflammatory immune responses
in IBD remain poorly understood. Data so far indicate
that chronic intestinal inflammation coincides with ele-
vated levels of pro-inflammatory cytokines (i.e., IL-12,
TNFa) [40], and the differentiation/activation of
pro-inflammatory DC-subsets and pathogenic CD4
+T
cells [41]. Accordingly, promising studies show that
inhibition of detrimental signals induced by stimulatory
bacterial products mitigates IBD progression [42-49].
Together, our data show that LTA plays a critical role
in the induction of the inflammatory responses and can-
not prevent mice from developing colitis. Contrary to
our findings, other studies have shown that lactobacilli-
LTA induces regulatory signals (i.e., IL-10) via Erk1/2
signaling, resulting in anti-inflammatory mechanisms
[30]. Other reports also indicate that commensal LTA
protects mice from DSS-induced colitis and ameliorates
impaired epithelial tight junctions [27,50]. This discre-
pancy may lay in the methodological approaches and
reagents that were used in these studies. Here we
demonstrate that LTA and LTA expressing bacteria pos-
ses the ability to stimulate innate immune component
cells, including DCs and macrophages, which in turn,
can trigger pathogenic IFNg-secreting CD4
+ T cells in
disease progression.
The role of IFNg expressed in the colon is unclear, as
it has been shown that this cytokine exerts protective
features in different models of inflammation [51]. For
example, in a murine model of multiple sclerosis, neu-
tralization of IFNg resulted in inflammatory immune
responses [52]. Similarly, in a mouse model of IBD,
IFNg h a sb e e ns h o w nt os u p p r e s sI L - 2 3[ 5 3 ] ,a n d
collagen-induced arthritis is induced in the absence of
IFNg signaling [54]. However, in the models we have
previously used for experimental DSS inducing epithelial
injury (i.e., leaky mucosa) resulting in colitis or
pathogenic CD4
+CD45RB
high T cell transfer; IFNg seems
to be involved in the pathogenesis of the induced colitis.
Additionally, IFNg contributes to intestinal pathology
and lethality in lipopolysaccharide-sensitization models
of toxic shock syndrome (TSS) [55,56]. Further studies
are needed to clearly elucidate the role of this cytokine
in colitis and the timing of its production during disease
progression.
Our results show that in vitro and in vivo, NCK2031
expressing LTA and purified S. aureus-LTA induce
intestinal immune activation resulting in the produc-
tion of TNFa and IL-12 and the development of pro-
inflammatory cells such as CD11c
+TNFa
+IL-12
+ DCs
and F4/80
+ macrophages that may contribute to an
undesired CD4
+IFNg
+TNFa
+ T cell pro-inflammatory
response seen in colitis. Conversely, treatment with
LTA-deficient NCK2025 elicited regulatory signals and
induced less inflammation, as demonstrated here and
previously [18,19]. We have previously demonstrated
the involvement of SlpA of L. acidophilus NCFM in
the immune regulation of DC functions [57]. Studies
are underway to better delineate the physiological role
of SlpA from this bacterium in vivo. Finally, an acute
colitis characterized by bloody diarrhea, ulcerations
and infiltrations with granulocytes can be induced in
mice that are exposed for several days to significantly
dissolved DSS polymers in drinking water [58,59]. As
seen in Figure 6, we also could confirm such clinical
s i g n sw h e nD S Sw a su s e dt oi n d u c ec o l i t i s .A d d i t i o n -
ally, our data clearly show not only the proinflamma-
tory nature of LTA but also the significantly
exacerbated disease progression in the colon of mice
that received LTA in the drinking water. This data
thus are in sharp contrast with the notion that LTA
plays a regulatory and does posses the ability to miti-
gate DSS-induced colitis as described previously [27].
In summary, oral administration of DSS to mice
induces an acute colitis, followed by a slow colonic
regeneration of the epithelium with a concomitant
exaggerated inflammation; furthermore LTA did not
reduce the levels DSS-induced colitis or rapid healing
of destructed epithelial tissues in our studies.
Conclusions
O u rd a t as t r o n g l ys u g g e s tt h at directed alteration of
two of the L. acidophilus-Slps did not ameliorate LTA-
induced pro-inflammatory signals and subsequent coli-
tis. Additionally, further studies are required to elucidate
t h er o l eo fL. acidophilus-Slps in the steady state of
normal gut homeostasis and in diseases such as colitis
and colon cancer where deregulated inflammation plays
a critical role in disease progression. Finally, LTA did
not mitigate DSS-induced colitis but induced further
colonic inflammation.
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